Clinical trial No longer in our active list Interventional Ages 15 to 40

Comparing different concentrations of sodium hypochlorite for treating irreversible pulpitis in teeth

Official title: Outcome Following Use of Different Concentrations of Sodium Hypochlorite as Wound Lavage and Hemostatic Agent in Partial Pulpotomy: A Randomised Control Trial

Run by Postgraduate Institute of Dental Sciences Rohtak · NCT06433245 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether using 3% or 5% sodium hypochlorite can help treat irreversible pulpitis in adult molars and improve patients' comfort and quality of life after the procedure.

Quick facts

Study typeInterventional
Ages15 Years to 40 Years
SexAll
Enrollment116 (estimated)
SponsorPostgraduate Institute of Dental Sciences Rohtak
Academic / other
Locations1 site (Rohtak, Haryana)
Trial IDNCT06433245 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with mature permanent mandibular molars exhibiting clinical signs of irreversible pulpitis and normal periapical status.

Probably not a fit

Patients with non-restorable teeth, necrotic pulp, or other significant dental issues will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of 3% versus 5% sodium hypochlorite (NaOCl) as a wound lavage and hemostatic agent during partial pulpotomy in mature permanent mandibular molars diagnosed with irreversible pulpitis. Participants will undergo a randomized control trial where clinical and radiographic outcomes will be assessed at 12 months, alongside evaluations of oral health-related quality of life (OHRQoL) and pain experiences at various intervals post-treatment. The study seeks to clarify the impact of different NaOCl concentrations on treatment success and patient comfort.

Why it matters

Potential benefit: If successful, this study could enhance the effectiveness of partial pulpotomy treatments, leading to better patient outcomes and reduced pain.

How similar studies have gone: Previous studies have indicated the importance of sodium hypochlorite in vital pulp therapy, but this specific comparative analysis of concentrations is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Mature permanent mandibular molars.
2. Teeth with clinical diagnosis of symptomatic irreversible pulpitis
3. Patients having normal periapical status with periapical index (PAI) score ≤ 2
4. Periodontally healthy teeth
5. Patients having physical status of class 1 or 2 according to ASA classification
6. Pulpal bleeding can be controlled within 6 minutes.
7. Presence of extremely deep carious lesion on radiograph -

Exclusion Criteria:

1) Non restorable teeth 2) Necrotic pulp evident upon exposure 3) Negative response to vitality test 4) Presence of sinus tract 5) Presence of soft tissue swelling 6) Radiographic signs of internal or external root resorption 7) Pregnant women

-

Where it's running

  • Pigds
    Rohtak, Haryana, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.